Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Impact of the Covid-19 Pandemic on the Diagnosis and Treatment of Skin Cancers, a Mini Review Publisher Pubmed



Aryanian Z1, 2 ; Balighi K1, 3 ; Goodarzi A4, 5 ; Sadeghi Nia A1, 3 ; Afshar ZM6 ; Hatami P1, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Dermatology, Babol University of Medical Sciences, Babol, Iran
  3. 3. Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
  7. 7. Behayand Cancer Team, Tehran, Iran

Source: Cancer Reports Published:2023


Abstract

Background: The SARS-Cov-2 pandemic has caused dermatologists around the world to adapt their practice in the aim of protecting patients with special clinical conditions such as those having skin cancers or premalignant conditions and some diagnostic or therapeutic programs would be suspended due to being infected to SARS-CoV-2. We focused the existing data in this regard through searching on PubMed, Google Scholar, and Scopus and tried to summarize recommendations for treating this group of patients in COVID era to provide a practical guide for clinicians. Recent findings: The number of diagnosed skin cancers dropped significantly since the beginning of the pandemic, specially in the peaks of various variants of the SARS-CoV-2 infection. The new guidelines allowed even a 3-month delay in excision and recommended surgery for non-melanoma growing skin cancers. Conclusion: Dermatologists should perform a careful, individualized risk–benefit assessment for their patients and consider some changes in routine protocols such as having a delayed diagnostic or therapeutic intervention. © 2023 The Authors. Cancer Reports published by Wiley Periodicals LLC.
Related Docs
1. Future Challenges and Opportunities for Cancer Screening in the Covid-19 Era, Health Policy and Technology (2023)